Clinical Trial Update: BELotaxel(Docetaxel) and bellOXa(Oxaliplatin) in Advanced NSCLC [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating the combination of docetaxel and oxaliplatin in advanced non-small cell lung cancer has completed, with results posted in August 2015…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Eloxatin (oxaliplatin)
• Taxotere (docetaxel)

Snippet

Sponsor: Chonnam National University Hospital | Conditions: Non-Small Cell Lung Cancer | Phase 2 | Status: COMPLETED | Results posted: 2015-08-17